Skip to main content
. 2018 Aug 23;51(5):242–247. doi: 10.3961/jpmph.18.092

Table 1.

Distribution of patients with NMIBC by risk status in the US National Cancer Institute’s Surveillance, Epidemiology, and End Results registries, 1988-2006 (n=29 326)

Variables n (%) Risk group (%)1
p-value
Low Intermediate High
Sex <0.013
 Male 21 740 (74.1) 37.0 45.2 17.8
 Female 7586 (25.9) 39.2 43.7 17.1
Race/ethnicity <0.013
 Non-Latino white 25 133 (86.7) 37.7 44.7 17.6
 Non-Latino black 1039 (3.6) 33.5 46.7 19.8
 Latino 1456 (5.0) 37.2 46.8 16.0
 Other 1374 (4.7) 36.5 42.9 20.7
Marital status <0.0013
 Married 19 219 (67.8) 38.5 44.3 17.2
 Unmarried2 9140 (32.2) 35.4 45.9 18.7
Age (mean±SD) 67.74±13.14 66.19±13.32 67.85±13.06 70.78±12.41 <0.0014

NMIBC, non–muscle-invasive bladder cancer; SD, standard deviation.

1

Low risk: stage Ta (grade I or II) and tumor size <3 cm; Intermediate risk: stage Ta, T1 (grade III/IV) and tumor size <3 cm; and High risk: carcinoma in situ (grade III or IV) and tumor size ≥3 cm.

2

The category of unmarried included single, separated, divorced, and widowed participants.

3

Chi-square test.

4

Student t-test.